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Abstract.  Chartins  are a unique class of three families 
of microtubule-associated proteins,  each consisting of 
several isoforms possessing varying degrees of phos- 
phorylation.  The most highly phosphorylated chartin 
isoforms are highly enriched in neuronal  cell fractions 
containing  microtubules and there is evidence that 
their phosphorylation may play a  role in promoting 
neurite outgrowth.  The present work describes the 
relationship between the phosphorylation state of char- 
tins and the presence of intact microtubules in long- 
term cultures of NGF-treated,  neurite-bearing PC12 
cells.  Cultures were depleted of microtubules by ex- 
posure to high concentrations  of depolymerizing agents 
for 2-24 h.  Radiolabeling of cellular proteins with 
[32p]orthophosphate or [35S]methionine  revealed that 
both the ongoing and steady-state phosphorylation of 
chartins  is markedly altered under these conditions. 
Two-dimensional isoelectric focusing by SDS-PAGE of 
whole cell extracts demonstrated that the more acidic, 
highly phosphorylated isoforms are diminished  with a 
concomitant increase in the more basic,  less phos- 
phorylated isoforms.  These phosphorylation changes 
were relatively specific for the chartins and were not 
observed for phosphorylated MAP 1.2,  phospho-13- 
tubulin,  or most other phosphoproteins.  Thus,  the 
phosphorylation state of chartins,  but not of other 
phosphoproteins,  is regulated by the presence of na- 
tive microtubules.  Despite depolymerization of micro- 
tubules, neurites remained extended for at least 24 h. 
Neurite elongation,  however, was arrested.  Micro- 
tubules, therefore,  may be required for extension,  but 
not for short-term maintenance  of well-established 
neurites.  Taxol,  which promotes tubule assembly and 
stability, does not,  conversely, drive phosphorylation 
of the chartins.  Instead,  taxol appeared to decrease the 
turnover of phosphate in microtubule-associated,  acidic 
chartin  isoforms.  These data suggest several models as 
to how chartin phosphorylation is regulated in neurite- 
bearing cells and indicate that phosphorylation of cyto- 
plasmic and microtubule-associated chartins occurs via 
different mechanisms. 
T 
hE structural  and functional  properties of the micro- 
tubular cytoskeleton  appear to depend, by essentially 
unknown mechanisms,  upon a diverse set of  molecules 
known as microtubule-associated proteins  (MAPs). t High 
molecular mass (36) and tau (9, 49) MAPs promote the poly- 
merization of microtubules from monomeric tubulin in vitro, 
suggesting a role for these proteins in the regulation  of the 
assembly state  of cellular  microtubules.  MAPs have  also 
been thought  to mediate  cross-bridging between microtu- 
bules and other cytoskeletal elements (26, 30, 44). Recently, 
evidence has  accumulated  linking  increases  in  these and 
other MAPs with neuritogenesis  (2,  7,  15, 20). Additional 
functions which may be performed in part by MAPs include 
maintenance  of cell shape (41), stability (24), and intracellu- 
lar motility (48). 
Since most MAPs are known to be substrates  for protein 
kinases (10, 20. 32, 37, 39, 45), modulation of phosphoryla- 
1. Abbreviations used in this paper: 2-D IEFxSDS-PAGE, two dimensional 
isoelectric focusing by SDS polyacrylamide gel electrophoresis;  MAP(s), 
microtubule-associated protein(s);  NGF, nerve growth factor. 
tion may be one mechanism for the regulation of MAP func- 
tions. This may be particularly  true for a class of MAPs first 
described by Pallas  and Solomon (39) and recently desig- 
nated  "chartins"  (34).  Several lines  of biophysical  and im- 
munological  evidence have demonstrated that  chartins  are 
distinct  from other classes of MAPs, including  tau proteins 
(2, 4, 34, 40, 49). In their initial study with cultured neuro- 
blastoma and PC12 cells cultured without nerve growth factor 
(NGF),  Pallas  and  Solomon  demonstrated  that  the  most 
highly phosphorylated variants  of chartin  MAPs are selec- 
tively enriched in cellular fractions  containing  components 
of the assembled microtubular cytoskeleton  (39).  Partly on 
this basis, these workers hypothesized that enhancement  of 
chartin phosphorylation could be involved in microtubule as- 
sembly.  Moreover,  since microtubules are major  compo- 
nents of the neuronal cytoskeleton and since microtubule for- 
mation appears to be required for generation  of neurites  (11, 
18, 51), it is possible that phosphorylated chartins may conse- 
quently play a role in neurite outgrowth. 
In  consonance  with  a  possible role  of phosphorylated 
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The Journal of Cell Biology, Volume 105, July 1987 277-290  277 Figure  I.  Identification of chartins  in a MAP-enriched fraction of long-term (>2 wk) NGF-treated  PCI2 cells. Cultures were incubated 
in the presence of 100 IsCi/ml of [3SS]methionine for 3 d and processed,  as described  in Materials  and Methods,  to isolate proteins of 
the microtubular cytoskeleton for separation by 2-D IEFxSDS-PAGE.  Equal numbers (90,000) of TCA-precipitable counts of this material 
were loaded onto IEF gels. Fluorograms of 4-d exposures from the SDS-PAGE are reproduced here. On the left is the pattern typical of 
long-term NGF-treated PC12 cells. The fluorogram on the right was generated from a culture plated and treated with NGF in the same 
manner and time as that on the left, the only exception being that 50 ~tM nocodazole was present in the culture medium for the last 6 h 
of incubation. All three chartin families, depicted by arrows (60-64 kD), triangles (64-72 kD), and arrowheads (80 kD), were markedly 
diminished in this fraction due to depolymerization of the microtubular cytoskeleton by nocodazole and their consequent extraction during 
a prior step. Similar results were obtained in three independent experiments. T, tubulin; A, actin. The separating gels were 7.5-12% acryl- 
amide with an isoelectric point range between 4.0 and 6.8. The basic end of the gel is to the left. Molecular mass markers are indicated 
by the black bars:  200, 116, 92,  66, 45, and 31 kD. 
chartins in the nervous system, these MAPs are present in 
the brain (34) as well as in murine neuroblastoma cells (39), 
cultured sympathetic neurons (4), and in the PC12 clonal line 
of rat  pheochromocytoma cells  (2,  7,  39,  52).  The  latter 
finding is of particular practical importance since PC12 cells 
have been widely used as a model to study neuronal differen- 
tiation and neuritogenesis (21, 22),  and,  recently, to detect 
and assess the functional role of MAPs in the nervous system 
(2, 7, 15, 20, 39, 52). When exposed to NGF, PC12 cells stop 
dividing,  and,  over the  course  of several  days to  weeks, 
elaborate an extensive network of neurites filled with micro- 
tubules.  After long-term (2-3 wk) exposure to NGF, there 
occurs an enhancement in the stability of PC12 cell microtu- 
bules  (3)  and substantial increases in the amount (15) and 
proportion  (2)  of total cellular tubulin  that  is  assembled. 
Along with this, the relative abundances of tau MAPs  (15) 
and of a phosphorylated high molecular mass MAP (15, 20) 
rise substantially. Moreover, under these conditions the com- 
position of chartin MAPs shifts such that the more acidic, 
phosphorylated forms are markedly elevated as  compared 
with the situation in non-NGF-treated PCI2 cells (2).  The 
latter observation is consistent with the hypothesis that char- 
tin MAP phosphorylation may be involved in regulation of 
microtubule properties and in neurite outgrowth. In further 
support of this, exposure of PC12 cells and sympathetic neu- 
rons to lithium ion has been found to selectively inhibit both 
NGF-promoted chartin MAP phosphorylation and neurito- 
genesis (7). Recently, forskolin and cholera toxin, activators 
of adenylate cyclase, were also observed to suppress both 
chartin phosphorylation and neurite outgrowth in PC12 cells 
(19). 
In the present studies we sought to further define the rela- 
tionship between chartin MAP phosphorylation and the po- 
lymerization state of cellular tubulin in a  neuronal model. 
That is, if phosphorylation of chartin MAPs may play a role 
in  microtubule properties,  does the converse occur-does 
formation or maintenance of highly phosphorylated chartins 
require the presence of microtubules? To approach this issue, 
we exposed long-term cultures of NGF-treated PC12 cells to 
agents known to either stabilize or destabilize microtubules 
in intact cells. We find that phosphorylation of chartins, but 
not of several other MAPs, is tightly linked to the presence 
of native, intact tubules.  Drug-induced depolymerization of 
microtubules leads to a marked diminution in the formation 
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cal increase in the more basic isoforms. However, in con- 
trast, promotion of cellular tubulin assembly and stabiliza- 
tion by exposure to taxol does not enhance chartin phos- 
phorylation but, in fact, appears to decrease the turnover of 
phosphate in the chartins. We also find that the neurites in 
long-term NGF-treated cultures can remain extended, but do 
not elongate, during at least 24 h of exposure to drug treat- 
ments that lead to a substantial reduction in the number of 
cellular microtubules. These and additional observations are 
used here to refine hypotheses regarding the role of chartins 
and their phosphorylation in neurite outgrowth. 
Materials and Methods 
Reagents 
Nocodazole (Aldrich Chemical Co., Milwaukee, WI) and podophyllotoxin 
(Sigma Chemical Co., St. Louis, MO) were dissolved in dimethyl sulfoxide 
(Fisher Scientific Co., Pittsburgh, PA) at concentrations of  50 mM and used 
at a  final dilution of 1:1000 in culture medium. An equal volume of the 
dimethyl solfoxide carrier was added to control cultures. Taxol,  stored fro- 
zen as a 20-raM stock solution in dimethyl sulfoxide, was diluted to a final 
concentration of 2 ~tM during exposure to the cultured cells. NGF was pre- 
pared according to the method of Mobley et al. (35). The chemicals used 
for gel electrophoresis were from Bio-Rad Laboratories (Richmond, CA) 
and those for sample preparation were from Fisher Scientific Co. and Sigma 
Chemical Co. Ampholytes (5-7 and 3.5-10)  were purchased from LKB In- 
struments, Inc. (Gaithersburg, MD). Protein A-Sepharose beads were from 
Pharmacia Fine Chemicals (Piscataway,  NJ). 
Cell Culture 
PC12 cells were grown as previously described (21) on collagen-coated 35- 
mm tissue culture dishes in RPMI 1640 medium supplemented with 10% 
horse serum and 5 % fetal calf serum. When non-NGF-treated cultures were 
required, PC12 cells were typically plated at densities from 5  ×  10  s to 1 
×  106 cells per 35-mm dish and harvested for analysis after 1-4 d. 
Cultures for NGF treatment were initially seeded with 5  x  105 cells per 
35-mm dish in RPMI 1640 medium initially containing 1% horse serum and 
50 ng/ml NGE Decreasing the serum concentration minimizes cell clump- 
ing and thus maximizes the extensiveness of the neuritic netv~rk (3). Once 
these cultures had elaborated a robust outgrowth of neurites (10 d-2 wk), 
the medium was  replaced with complete medium plus 50  ng/ml NGE 
Clumping at this time after NGF treatment was not a problem. These cul- 
tures were always grown in the presence of NGF for 2 wk or longer before 
use in experiments. A previous study has established that the serum concen- 
tration in the culture does not affect the NGF-promoted regulation of chartin 
phosphorylation (2). 
To examine the growth of individual neurites, more sparsely plated cul- 
tures were required. Approximately 60,000-125,000  cells were seeded onto 
35-mm culture dishes in complete medium containing 50 ng/ml NGF for 
2 wk, at which time nocodazole was added to some of the cultures at a final 
concentration of 50 laM. Individual neurites were photographed  just before 
drug treatment and then 2-14 h afterwards. 
Racliolabeling 
Metabolic radiolabeling of PC12 cell proteins was carried out as previously 
described (2, 20) in the presence of either carrier-free [a2p]otthophosphate 
(50-500 ltCi/ml) or 50-100 ~tCi/rnl [35S]methionine (1,1130 Ci/mmol), both 
from New England Nuclear (Boston, MA). For NGF-treated cultures, the 
factor was also present during the exposure to isotope. In some experiments, 
as noted in the text, nocodazole, podophyllotoxin, or taxol were also present 
during part of the labeling period. 
Sample Preparation 
Whole Cell Lysates.  Total cell proteins of cultures washed with PBS (16) 
were solubilized immediately in SDS sample buffer (62.5 mM Tris-HC1, 
2%  SDS, 2.5 mM EGTA, 2.5 mM EDTA,  10%  glycerol, 0.001% brom- 
phenol blue, pH 6.8) and placed in a boiling water bath for 5 rain before 
analysis by SDS-PAGE. For two-dimensional isoelectric focusing by SDS- 
PAGE (2-D IEFxSDS-PAGE), ceils were solubilized in a harvest solution 
appropriate for loading onto the IEF gels (8.5 M  urea, 4.5%  NP-40, 5% 
beta-mercaptoethanol, 0.2 % SDS, 250 mM NaCI, 2.4 mM EDTA, 2.4 mM 
EGTA, 3% ampholytes 5-7,  and 0.8%  ampholytes 3.5-10). 
Extraction Procedures. Preparations enriched in MAPs were generated 
from cells attached to culture dishes as described by Burstein et al. (7) using 
modifications of the procedures of Solomon et al. (46). The solnhilized pro- 
teins in the Triton/glycerol (stabilized) and calcium (destabilized) extracts 
were  precipitated  with  9  vol  of ice-cold methanol  and  centrifuged  at 
40,000  g.  The pellets were solubilized either in the harvest solution used 
for IEF or in PBS containing 1% SDS for immunoprecipitations. The cellu- 
lar residues remaining on the dish after these extractions were, in some 
cases, scraped up and solubilized in the IEF harvest solution. 
Gel Eiectrophoresis 
Discontinuous slab gel electrophoresis was carried out by the method of 
Laemmli (27) on 32-cm, 6-12%  gradients of polyacrylamide. Molecular 
mass standards (Bio-Rad Laboratories or Sigma Chemical Co.) were run 
alongside the samples in each experiment. The gels containing proteins la- 
beled  with  [32p]orthophosphate  were  fixed,  (50%  ethanol,  10%  acetic 
acid), stained (0.2% Coomassie Brilliant Blue in 50% ethanol, 10% acetic 
acid), and destained (10% ethanol, 10% acetic acid), after which they were 
dried and placed in contact with Kodak XAR-5 x-ray film to produce an 
autoradiographic image. 
Two-dimensional electrophoresis of protein samples was performed ac- 
cording to the method of O'Farrell (38), with the following modifications. 
IEF gels for the first dimension (10 M urea, 4.1% acrylamide, 2.2% NP-40, 
3.0%  ampholytes 5-7,  0.8%  ampholytes 3.5-10)  were pre-run at constant 
voltage for 600 Vb (15 rain at 200 V, 30 min at 300 V, and 60 min at 400 
V) after which samples were loaded and subjected to a constant voltage of 
500 V for 17 h. Separation of  proteins in the second dimension was on 16-cm 
slab gels containing 7.5-12 % gradients of polyacrylamide. Molecular mass 
standards, similarly embedded in 5-mm sections of tube gels, were run 
along with each experimental IEF gel sample. Gels were fixed, stained, and 
destained as described above, and those labeled with 32p were dried and 
placed in contact with Kodak XAR-5 x-ray film and a Cronex Lightning Plus 
enhancing screen (DuPont Co., Wilmington, DE). Exposures of 5 d-3 wk 
were used to produce autoradiograms. Gels containing 35S-labeled proteins 
were immersed in 1 M salicylic acid after removing fixative by three 20-min 
washes in deionized water (8). After drying, the gels they were exposed to 
preflashed XAR-5 x-ray film (28) and kept at  -70°C (6)  for 1 d-3 wk. 
Immunoprecipitations 
Whole cell cultures or MAP fractions prepared as above from 32p-phos- 
phate labeled PC12 cells were solubilized in sample buffer containing 1% 
SDS. These were incubated at 4 ° overnight with a chartin antiserum (1:50) 
(34) provided by Dr. Frank Solomon (Dept. of  Biology, Massachusetts Insti- 
tute of Technology,  Cambridge, MA), a MAP I antiserum (1:200)provided 
by Dr. Nicholas Cowan (Dept. of  Biochemistry, New York University Medi- 
cal Center,  New York),  or an antibody to l~-tubulin  (1:300,  Amersham 
Corp., Arlington Heights, IL). The immunoreaction was carried out in Tris- 
buffered (pH 8.0) saline containing 0.1%  SDS,  1%  Triton X-100, 25 mM 
NaE 5 mM EGTA, 5 mM EDTA, 2 mM phenylmethylsulfonyl  fluoride, and 
100 kallikrein inhibition units/mi aprotinin followed by precipitation of anti- 
gen-antibody complexes with protein A-Sepharose beads. Proteins were 
then solubilized in sample buffer and separaled either on a one-dimensional 
slab gel or by 2-D IEFxSDS-PAGE as described above. 
Electron Microscopy 
Cultures were rinsed three times with warm PBS followed by fixation (2.5 % 
glutaraldehyde in PBS, pH 7.4,  for 1 h), osmication (1% osmium for 20 
rain), and dehydration. After infiltration and embedding with fresh Epon 
812, silver-light gold sections were cut on an ultramicrotome and stained 
with lead citrate and uranyl acetate for observation with a JEOL S100 trans- 
mission electron microscope at 80 kV. In most cases, each experimental 
treatment was replicated in a  second independent trial. 
Aletta and Greene Microtubules Regulate Chartin  Phosphorylation  279 80~ 
eS o 
f 
O  • 
A  • 
o 
80~  • 
32p  E  F 
0  •  • 
64-72~ 
ol  °2 
C 
•  o3 
Figure 3. Metabolic radiolabeling of microtubule-associated char- 
tins from NGF-treated PC12 cells using [3SS]methionine (72 h in- 
cubation) or [32P]orthophosphate (1.5-2 h incubation) reveal simi- 
lar, but not identical patterns. Microtubule fractions were prepared 
from the labeled cells and resolved by 2-D IEFxSDS-PAGE. Trac- 
ings of the chartin MAPs present in the resulting fluorograms and 
autoradiograms are enlarged here for easier comparison. The mem- 
bers of the 60-64-, 64-72-, and 80-kD chartin families are denoted 
by numbers, upper case letters, and lower case letters, respectively. 
The patterns are very similar except for isoforms A and B, which 
are not detectably phosphorylated. Isoform B is present at very low 
levels and does not appear in photographic reproduction. The open 
spots in the 32P-labeled material were not detectable in non-NGF- 
treated  PCl2  cells nor in the zsS-labeled material.  There is also 
one open spot within the 80-kD string of the sss pattern that does 
not appear to be a MAP since it is still present in abundance after 
depolymerizing  treatments. 
Results 
Detection and Identification of the Chartin MAPs 
Detection and identification of the three chartin families in 
NGF-treated PC12  cells and of their characteristic associa- 
tion with microtubules was achieved using the principles de- 
scribed by Solomon et al.  (46)  for preparing Ca++-extracts 
enriched in MAPs (see Materials and Methods for details). 
2-D IEF×SDS-PAGE separation of the proteins in such ex- 
tracts of long-term NGF-treated cultures  labeled  for 72  h 
with [3SS]methionine  is shown in Fig.  1. The chartin MAPs 
are present as three characteristic strings of protein spots in 
the molecular mass ranges of 60-64, 64-72, and 80 kD and 
in the pI range between 6.3  and 6.8  (Fig.  1;  see also refer- 
ences 2, 4, 39, 52). Peptide mapping studies have previously 
demonstrated that each of these series of  protein spots consti- 
tutes a distinct  family (2,  39).  As expected of proteins as- 
sociated with polymerized microtubules, all three series of 
proteins are substantially diminished or absent from MAP 
fractions of cells treated with microtubule-depolymerizing 
agents before extraction (Fig.  1 B). As noted below, further 
verification of the identity of the 60-64-kD proteins as char- 
tins  was  obtained  on  the  basis  of immunological  cross- 
reactivity. 
To facilitate resolution of the three families in whole cell 
extracts (cf. Figs, 2, 6, and 9), our gel system has been some- 
what modified from those previously used to detect the char- 
tins (2, 39). This has allowed us to study the relative abun- 
dance of chartin  family member spots in whole cells after 
experimental manipulations and to minimize the uncertain- 
ties associated with possible translocations among different 
cellular compartments and/or generation of artifactual poly- 
peptides during extraction procedures. 
Past studies have revealed that the chartin MAPs are phos- 
phorylated (2,  7, 39, 52).  After [32p]orthophosphate label- 
ing of PC12 cells, most of the chartin MAP isoforms in whole 
cell  extracts can be detected  in  autoradiograms generated 
from 2-D IEF × SDS-PAGE. Long-term treatment of the cells 
with NGF results in an increased intensity as well as an in- 
creased number of polypeptide spots in the acidic region of 
each family of chartin MAPs (Fig. 2; see also reference 2). 
These NGF-inducible changes appear to be generated post- 
translationally, at least in part, by progressive phosphoryla- 
tion  reactions  that  convert the  substrate proteins  to  more 
negatively charged isoforms (2, 39).  Several of these acidic 
forms  were  not  detectable  in  the  non-NGF-treated  cells 
(open arrows in Fig.  2 B). 
Fig. 3 compares the 2-D IEF×SDS-PAGE profiles of char- 
tins present in the MAP fraction of NGFotreated PC12 cells 
labeled either with [32p]orthophosphate (2 h) or [3sS]methi- 
onine (3 d) (see also reference 2). For the most part, the pat- 
terns are similar, with the notable exceptions being the pro- 
teins designated A and B of the 64-72-kD family which are 
not detected by phosphate labeling.  The absence of phos- 
phate label in these and several other chartin proteins has 
Figure 2. Effects of nocodazole on the incorporation  of [32p]orthophosphate into chartins as detected by 2-D IEFxSDS-PAGE of whole 
PC12 cell extracts. Non-NGF treated PCI2 cells (A), NGF-treated (>2 wk) PCL2 ceils (B), and NGF-treated (>2 wk) PC12 cells incubated 
with 50 tiM nocodazole for 13 h (C) were labeled with [32p]orthophosphate for 2 h. In the latter case, nocodazole was also present during 
the time of labeling. Whole cell extracts were prepared and equal numbers of "IV_.A-precipitable  cpm (250,000) were loaded onto the gels. 
The autoradiograms shown (left) were obtained after a 5-d exposure in the presence of an enhancing screen. The chartin proteins are found 
within the area demarcated by brackets. The spots within these areas were traced and are shown enlarged approximately four and a half 
times (right). The curved arrows mark the members of the 60-64-kD chartin family; the straight arrows, the 64-72-kD family; and the 
arrowheads, the 80-kD family. Open symbols point out phosphorylated chartins not detectable in non-NGF-treated  and drug-treated cells. 
Phosphorylated 13-tubulin, identified by its comigration with the Coomassie-stained tubulin visible on the dried gel, is circled in the auto- 
radiograms.  Molecular  mass markers (kD) appear along the left side. The basic end of each gel is to the left. 
Aletta and Greene Microtubules Regulate Chartin Phosphorylation  281 Figure 4. Immunoprecipitation of phosphorylated chartins. A MAP-fraction from long-term NGF-treated PC12 cells, metabolically labeled 
with [32p]orthophosphate, was incubated with an anti-ehartin antiserum provided by Dr. Frank Solomon (34). After immunoprecipitation 
(see Materials and Methods) from 385,000 cpm (two-dimensional) or 275,000 cpm (l-D),  antigen-antibody  complexes were solubilized 
in sample buffer and subjected to either 2-D IEFXSDS-PAGE or 1-D SDS-PAGE. The resultant autoradiograms shown here were produced 
by exposing the dried gels to film either for 3 wk (2-D) or 2 wk (l-D) with enhancing screens. By overlaying with a two-dimensional auto- 
radiogram generated from the same MAP fraction before immunoprecipitation, the four spots (arrowheads) were found to line up precisely 
with spots 1-4 of the 60-64-kD chartin family (cf. Fig. 3). By immunoprecipitation followed with 1-D analysis, the 64-kD (arrowhead) 
and 80-kD (arrow) families were present in the MAP fraction from NGF-treated (+), but not from untreated (-) PCI2 cells. Lane C is 
a control incubation of the (+) material without the chartin antiserum. 
been noted before (2, 39). The patterns in the MAP fractions 
are also similar to those seen in whole cell extracts (cf. Figs. 
2 B and 3, bottom, and 6 B and 3, top; see also reference 2). 
To further confirm the identity of the proteins in our study 
as chartins, cells were metabolically radiolabeled, MAP frac- 
tions thereof were subjected to immunoprecipitation with af- 
finity-purified  antibodies  (from  antiserum  4-81)  prepared 
against brain chartins (34), and the starting and immunopre- 
cipitated proteins  were analyzed by 2-D  IEFxSDS-PAGE 
and autoradiography or fluorography. Superimposition of the 
autoradiograms  or  fluorograrns  revealed  that  each  of the 
members of the 60-64-kD family (corresponding to Nos. 1-4 
in Fig.  3)  labeled with either [32p]orthophosphate (Fig.  4) 
or [35S]methionine  (not shown) was specifically recognized 
by the antiserum. Several acidic members of the 80-kD fam- 
ily were also detectable after long-term exposure of fluoro- 
grams of 3sS-labeled material (data not  shown),  but  these 
proteins were more efficiently detected as a single band after 
32p labeling and separation on a  one-dimensional gel (Fig. 
4).  Attempts  to  immunoprecipitate detectable  amounts  of 
chartins from whole cell lysates were not successful. 
Nocodazole Treatment Markedly Alters 
the Phosphorylation Pattern of  the Chartin MAPs 
Since it has been reported that there is a selective association 
of the more highly phosphorylated chartins  with microtu- 
bules (39), we were interested in establishing the relationship 
between the phosphorylation state of these proteins and the 
assembly state of the microtubular cytoskeleton. As a means 
toward this end, we assessed the effects of drug-induced de- 
polymerization of microtubules on the phosphorylation of 
chartins in whole PC12  cells. 
Fig. 2 compares the phosphoprotein patterns in extracts of 
whole PC12 cells, either without NGF-treatment, with NGF 
treatment for several weeks, or with NGF treatment for sev- 
eral  weeks and  exposure to  50  ~tM  nocodazole  for  15  h. 
Labeling with 32p was carried out during the 2  h  immedi- 
ately before generation of whole cell lysates. Under the latter 
conditions of nocodazole treatment there is a striking loss of 
microtubules from the cells (see Fig. 8) and a concomitant 
substantial reduction of tubulin and chartins in the microtu- 
bule fraction (cf. Figs.  1, 2, and reference 7).  As shown in 
Fig. 2, nocodazole pretreatment significantly affects the pat- 
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fects  of  nocodazole  and  podo- 
phyllotoxin  on  phosphorylation 
of MAP 1.2 and the 64-kD char- 
tin MAP. (A) PC12 cells were la- 
beled for 2 h with [32P]orthophos- 
phate, solubilized in sample buffer 
and subjected to SDS-PAGE (6- 
12 % acrylamide gradient). Equal 
amounts  (100,000 cpm) of TCA- 
precipitable  radioactivity  were 
loaded  into  each  lane.  The au- 
toradiograph  was  obtained  by 
overnight  exposure  of the  dried 
gel to x-ray film. The lanes con- 
tain material from: (lane 1 ) PC12 
cells never exposed to NGF; (lane 
2)  NGF-treated  (>2  wk  NGF) 
cells;  (lane 3) NGF-treated cells 
+  50  ~tM nocodazole  for 20 h; 
(lane 4) NGF-treated cells  +  50 
I~M nocodazole for 5 h; (lane 5) 
NGF-treated  cells  +  50  ktM 
podophyllotoxin  for 20 h;  (lane 
6)  NGF-treated  cells  +  50  ~tM 
podophyllotoxin for 5 h. For cul- 
tures treated with nocodazole or 
podophyllotoxin,  the  drug  was 
present  during  exposure  to  la- 
beled phosphate. The arrow points 
out the migration distance of the 
64-kD MAP and the triangle, that 
of  MAP 1.2. The positions of  mo- 
lecular  mass standards  are indi- 
cated at the right (as M~ x  10-3). 
(B) Immunoprecipitations (as de- 
scribed  in  Materials  and  Meth- 
ods)  of 32P-labeled MAP  1  or 
13-tubulin from whole cell lysates 
of  untreated (-), long-term NGF- 
treated  (+),  or long-term  NGF- 
treated  and  nocodazole-treated 
(+N) PCI2 cells. The first three lanes show the total phosphoprotein patterns from which the subsequent immunoprecipitations were per- 
formed (50,000 cpm/lane;  nocodazole, when present,  for 24 h). The next three lanes are from MAP 1 immunoprecipitations from equal 
amounts of radioactive material (600,000 cpm; nocodazole, 24 h), and the last three lanes from 13-tubulin immunoprecipitations  (1.5  x 
106 cpm; nocodazole,  2 h). 
tern of phosphate incorporation into the chartins.  First, the 
intensity of labeling and the number of acidic variants in each 
chartin family are reduced. Second, the more basic members 
of each string of proteins are increased in labeling intensity 
(Fig.  2  C).  Similar qualitative changes  are  obtained  with 
2-24 h of nocodazole treatment. Thus, the phosphorylation 
of the more acidic isoforms within each chartin family is de- 
pendent upon the presence of native, polymerized tubulin in 
the cells. 
The amount of 13-tubulin which is phosphorylated in long- 
term  NGF-treated  PC12  cells  is  also  greatly increased  in 
comparison with that found in PC12  cells cultured without 
NGF  (Figs.  2  and  5  B;  see  also  references  2  and  7). 
Identification of phosphorylated 13-tubulin in our system is 
based on (a) its electrophoretic co-migration with authentic 
13-tubulin, (b) selective enrichment in microtubule fractions, 
(c) loss from these fractions after exposure of cells to depoly- 
merizing agents, and (d) recognition by anti-13-tubulin anti- 
body (Fig. 5 B). In comparison with the observed effects on 
the chartins,  however, treatment with nocodazole does not 
interfere with 13-tubulin phosphorylation to the same extent 
(cf. Figs. 2 and 5 B). In several different experiments, phos- 
photubulin was somewhat diminished, but still easily detect- 
able under the same conditions that drastically altered char- 
tin phosphorylation. 
Comparison with Effects of  Depolymerizing Agents 
on MAP 1 Phosphorylation 
We have previously resolved one of the phosphorylated char- 
tin  MAPs  (apparent Mr 64,000)  present in  whole  cell  ly- 
sates on one-dimensional SDS polyacrylamide gradient gels 
(2, 7) along with another phosphorylated MAP of high mo- 
lecular mass, designated MAP 1.2 (20).  The identity of the 
Mr 64,000 species as a chartin was confirmed by its immu- 
noprecipitation (Fig. 4) with an anti-chartin antiserum (34). 
Aletta and Greene Microtubules Regulate Chartin Phosphorylation  283 Figure 6.  Microtubule depolymerization produced by exposure of NGF-treated PC12 ceils to 50 IsM noeodazole for 2 h (A) or 14 h (B) 
causes a decrease in steady-state levels of total cellular acidic ehartins and a reciprocal increase in the respective basic isoforms. Cells 
were solubilized in IEF harvest solution after 72 h of radiolabeling in medium containing 100 ~tCi/ml of [35S]methionine. Nocodazole was 
added for the times indicated before solubilization. Proteins were separated on 7.5-12  % aerylamide gradient gels. Arrowheads demarcate 
the 80-kD family of chartins from the most basic to the most acidic isoforms (left to right).  Open symbols signify the 72-kD family, and 
arrows, the 64-kD family. A displays the entire fluorogram from the shorter time course experiment,  which was replicated in a second 
independent experiment. The results in B, depicting only the area of the gel containing the ehartins, were also reproduced in three similar 
experiments with nocodazole present  for 15, 20, or 24 h. A, aetin;  Z  tubnlin. 
Likewise, a previous study (20) has demonstrated that the 
high molecular mass species is recognized by anti-MAP  1 
antiserum.  In the present study,  we have used an antibody 
generated against the fusion protein from a  MAP  I  clone 
(31), kindly provided by Dr. Nicholas Cowan, to corroborate 
this finding (Fig. 5 B). Long-term NGF treatment results in 
a large increase in the levels of both of these species (2, 7, 
20).  Using one-dimensional gels,  we asked whether drug- 
induced depolymerization of microtubules would affect the 
phosphorylation  of  both  classes  of  MAPs  equally  and 
whether  it  would  affect  that  of  other  cellular  proteins. 
32p-labeled  protein extracts of whole cells pretreated  with 
50 IxM podophyllotoxin or 50 I~M nocodazole for 2-20 h be- 
fore labeling were resolved on SDS polyaerylamide gradient 
gels.  After both short (2  h)  and  longer (20 h)  drug treat- 
ments, phosphorylation of the 64-kD chartin MAP was sup- 
pressed, while phosphorylation of MAP  1.2 was unaltered 
or only slightly affected. Fig. 5 A is typical of the results oh- 
mined in five independent experiments of this type.  Over- 
night drug treatment also often gave rise to increased phos- 
phorylation of a 24-kD protein, the significance of which is 
unclear. 
Despite the effects of podophyllotoxin and nocodazole on 
chartin MAP phosphorylation, these drugs do not produce 
The Journal of Cell Biology, Volume  105, 1987  284 Figure 7. PC12  cell neurites grown in the presence of NGF for 4 wk. No drug treatment (A) or 50 ~tM nocodazole for the final 20 h (B). 
Bar. 100 ~tM. 
generalized effects on other cellular phosphoproteins. Cul- 
tures equally plated with cells and treated with or without 
drugs  exhibited  similar  incorporation  of [32P]orthophos- 
phate into TCA-precipitable protein as determined by liquid 
scintillation spectrometry (<1% difference, n  =  5). Further- 
more, with the exceptions of the chartins and occasionally 
the 24-kD band, as shown in Figs. 2 and 5, nocodazole and 
podophyllotoxin have little apparent effect on phosphate in- 
corporation into most cellular phosphoproteins. 
Steady-State Levels of  Chartin MAPs Are Altered 
by Treatment with Microtubule-depolymerizing  Agents 
To  determine  the  effect of microtubule depolymerization 
upon the steady-state levels of the chartin MAPs, we labeled 
NGF-treated cultures with [35S]methionine  for 3 d. In some 
cultures, microtubule depolymerizing  drugs were added dur- 
ing the last 2-20 h of incubation. The characteristic pattern 
of chartins could be observed in 2-D IEF×SDS-PAGE gels 
of whole cell extracts prepared from control, untreated cul- 
tures (Fig.  6, A and B,  top).  As with  [32p]orthophosphate 
labeling (Fig. 2), there was a clear shift in the distribution 
of chartin isoforms in response to microtubule depolymer- 
ization.  Fig.  6 A demonstrates that even after only 2  h  of 
nocodazole treatment, the quantities of the acidic members 
of the three families of chartin proteins are reduced, with 
concomitant increases  in  levels of the  more basic  family 
members. Fig. 6 B shows a more pronounced effect  after 14 h 
of drug treatment. Comparable findings were obtained with 
podophyllotoxin. These observations appear to reflect the 
effects of depolymerization on chartin phosphorylation and 
show that this response occurs for the entire cellular content 
of chartin proteins. 
Neurites Can Remain Extended Even after 
Drug-induced Depolymerization of  Most Microtubules 
To assess  the effects of anti-microtubule treatments at the 
morphological level and to determine the effects of microtu- 
bule loss on neurite maintenance and growth, drug-treated 
cultures were examined by both light and electron micros- 
copy. In long-term NGF-treated cultures (>2 wk) the pres- 
ence of depolymerizing drugs for up to 24 h did not produce 
widespread retraction or dissolution of neurites (Fig. 7 B). 
Beyond this time the drugs appeared to elicit toxic responses, 
as evidenced by progressive deterioration of both cell bodies 
and neurites. 
Ultrastructural  analysis  of the  neurites  by transmission 
electron microscopy indicated that after 2  h  of drug treat- 
ment, microtubules were no longer oriented in parallel bun- 
dles, but instead appeared as disjointed, wavy tubular seg- 
ments (data not shown). Overnight drug treatment resulted 
in further losses of microtubules so that only a  few of the 
aberrant type of tubules remained (Fig. 8). In addition to the 
loss of microtubules, we noticed the presence of filamentous 
structures not typically observed in control material (arrow- 
Aletta and Greene Microtubules Regulate Chartin Phosphorylation  285 Figure 8. Electron micrographs of PC12 cell neurite bundles generated by 4-wk exposure to NGF and treatment for 18 h with either 50 gM 
nocodazole (B) or drug carrier alone (A). Microtubules  (arrows) run for long distances in the longitudinally sectioned control material 
and fill much of the cytoplasm, but they are greatly diminished in number and extent in the drug-treated neurites. Filamentous material 
(arrowheads) was never observed in the control neurites (see also references 29 and 33) but was often encountered in favorably sectioned 
material from the drug-treated  neurites. Bar, 500 rim. 
heads in Fig. 8 B). These findings confirm that nocodazole 
causes depolymerization of PC12 microtubules and indicate 
that long-term NGF-treated cultures can maintain neurites 
for at least  1 d  in the absence of almost all microtubules. 
We also examined the effect of nocodazole on the elonga- 
tion of neurites. This was carried out in low density cultures 
so that single, nonfasciculated processes could be observed. 
Measurements  from  photographs  made  of the  same  in- 
dividual neurites immediately before and 14 h after adding 
50  aM nocodazole to cultures demonstrate that elongation 
does not occur in the presence of the drug (Table I). Thus, 
loss of microtubules rapidly affects the elongation, but not 
maintenance,  of neurites. 
Taxol Does Not Drive Phosphorylation 
of  Charu'n MAPs 
Since microtubule depolymerization results  in  chartin  de- 
phosphorylation,  we wished to know,  conversely, whether 
conditions favoring microtubule assembly or stability would 
enhance chartin phosphorylation.  Taxol is a  plant alkaloid 
that has been used experimentally to promote microtubule 
assembly in vitro as well as to protect assembled microtu- 
bules from depolymerizing treatments (14, 42, 43). Recently 
taxol was used to demonstrate that phosphorylation of [3-tu- 
bulin is polymerization dependent in murine neuroblastoma 
cells (17). We therefore tested whether this drug would also 
drive increased phosphorylation of the chartin MAPs. 
Table L Effect of  Nocodazole on the Elongation 
of PC12 Neurites 
Length change 
Treatment  (5:  SEM)  n 
/tm 
Control  +60  +  9  14 
Nocodazole (50  txM)  -2  +  5  8 
Sparsely  plated cultures of NGF-treated  cells were prepared as described in 
Materials and Methods.  Selected areas containing single, unfasciculated neu- 
rites were photographed  through phase-contrast optics immediately  before ad- 
dition of nocodazole  (50 IxM final concentration)  or of an equal volume of the 
dimethyl sulfoxide solvent (control).  These areas were marked on the bottoms 
of the culture dishes with different  colors of ink and a  second  set of photo- 
graphs was taken of the same neurites 14 h later. The lengths of neurites before 
and after treatment were determined from photographic prints of each field. 
The Journal of Cell Biology, Volume 105,  1987  286 Figure 9. Effects of taxol on the phosphorylation  and steady-state levels of the cellular content of chartins.  PCI2 cells were grown in the 
presence of NGF for >3 wk along with [32p]orthophosphate for the final 2 h (A, B, and C) or [35S]methionine for the final 72 h (D, E, 
and F). The cultures were also either untreated (A and D) or treated with 2 ~tM taxol for either the final 2.5 (B and E), 24 (C), or 21.5 
(F) h of culture. Total cell proteins were then solubilized and resolved by 2-D IEF×SDS-PAGE.  The area on the gel containing the chartin 
MAPs is enlarged. Basic to acidic pls run from left to right. Each chartin MAP family lies between their respective symbol pairs: (arrow- 
heads) 80 kD; (triangles) 64-72 kD; (arrows)  60-64 kD. Note that the most basic member of the 35S-labeled 72-kD family is not phos- 
phorylated (see Fig. 5). Each radiolabeling experiment submitted to 2-D analysis was replicated in an independent trial and the effect on 
the 32p-labeled 64-kD family was verified in two additional experiments with SDS-PAGE. 
Long-term NGF-treated (>3 wk) PC12 cells were exposed 
to taxol for 0.5 h-1 d and then to [32p]orthophosphate for an 
additional 2 h in the presence of taxol. Total cell lysates were 
analyzed  for  phosphorylated  chartins  by  2-D  IEF×SDS- 
PAGE. As illustrated in Fig. 9, A-C, it was clear that phos- 
phorylation of the chartin isoforms had not been driven fur- 
ther by taxol. In fact, there was an apparent inhibition of the 
labeling of several acidic chartin MAPs and an apparent in- 
crease  in  the  levels  of the  more  basically  charged  phos- 
phorylated chartins (Fig.  9, A-C). 
Parallel experiments (Fig. 9, D-F) were carried out to as- 
sess the effects of taxol on the total cellular composition of 
chartins. Cultures (>3 wk of NGF treatment) were exposed 
to  [35S]methionine  for 3  d.  Taxol was added either during 
the last day or last 2 h  of labeling.  In consonance with the 
results achieved with phosphate labeling,  taxol did not in- 
crease the overall cellular levels of the more acidic chartin 
isoforms. However, while taxol led to a  rise in the relative 
levels of the more basic isoforms, the taxol-dependent de- 
crease in relative levels of  the acidic isoforms shown by phos- 
phate labeling was much less evident with long-term methio- 
nine labeling. These observations suggest that taxol may not 
drive either the phosphorylation or dephosphorylation of the 
acidic chartin isoforms, but rather that it may interfere with 
the turnover of phosphate in these MAPs. 
To further probe the effects of taxol on the chartin MAPs, 
[35S]methionine-labeled cultures  (with  >3  wk of NGF ex- 
posure) were treated with this agent for 2 h and then sequen- 
tially extracted with a  microtubular stabilizing buffer con- 
taining 0.1%  Triton X-100 and 2 M  glycerol, and then with 
a  destabilizing  buffer containing  3  mM  Ca  ++.  The  taxol- 
stabilized material left bound to the culture dish  was then 
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periments revealed that the most acidic forms of the chartin 
MAPs  were highly enriched in the taxol-stabilized, Ca  ÷+- 
resistant cytoskeletal fraction and that only trace amounts of 
these appeared in the Triton and Ca  +÷ extractions (data not 
shown). These observations suggest that the acidic, but not 
more basic,  chartin  isoforms can  strongly  associate  with 
taxol-stabilized tubules. This is consistent with the findings 
of Pallas and Solomon (39), who reported an enrichment of 
the  more  highly  phosphorylated chartin  isoforms  in  the 
microtubule fraction of cultured murine neuroblastoma cells 
and PCI2 cells never exposed to NGE 
Discussion 
Dependence of Chartin Phosphorylation 
on the Presence of Tubules 
This study has demonstrated that the state of phosphoryla- 
tion of three MAP families in process-bearing PCI2 cells is 
dependent on the presence of microtubules. We have distin- 
guished these MAPs from tau proteins and have identified 
them as chartins based upon (a) their characteristic migra- 
tion pattern on 2-D IEF×SDS-PAGE (2, 4, 39, 52) and (b) 
their precipitation upon boiling.  In addition,  the 64-  and 
80-kD forms were specifically immunoprecipitated with an 
anti-chartin antiserum (34). Drug-induced depolymerization 
of microtubules led to a decrease in incorporation of phos- 
phate into chartins, to depletion of the cellular complement 
of acidic highly phosphorylated chartin isoforms, and to an 
increase in the cellular content of more basic,  less phos- 
phorylated chartin isoforms. 
Dependence of the state of cellular chartin phosphoryla- 
tion on microtubules could arise from one or more alterna- 
tive mechanisms. One is that phosphorylation takes place on 
intact microtubules.  In this case,  chartins associated with 
tubules may be exposed to a  tubule- or cytoskeletal-asso- 
ciated  kinase  or,  alternatively,  could be  better  substrates 
for a  soluble kinase.  A  second possibility  is  that  chartin 
phosphorylation occurs entirely in the soluble phase and is 
effected by a tubule-activated or -dependent kinase. A third 
possibility is that the cellular state of chartin phosphoryla- 
tion is regulated by phosphoprotein phosphatases.  For in- 
stance, chartins could be protected from such enzymes while 
associated with tubules, and, upon tubule depolymerization, 
become vulnerable to dephosphorylation. The present ex- 
periments do not permit us to distinguish among such alter- 
natives. 
Drug-induced depolymerization of microtubules in living 
cells was used to assess phosphorylation of chartins present 
in whole cell lysates. One possible outcome was that each 
isoform within the three families would simply be released 
from assembled tubules with merely a change in intracellular 
location and with no change in either the number ofisoforms 
or in the extent of each one's phosphorylation. Alternatively, 
de novo phosphorylation of only those isoforms enriched in 
assembled tubules (39) might have been particularly affected 
and the  cytoplasmic isoforms left unaffected. In  fact,  we 
found that both the ongoing phosphorylation and steady-state 
levels of all of the isoforms were altered. After depolymer- 
ization, not only were the more acidic chartin isoforms di- 
minished, but the more basic isoforms in each family were 
proportionally increased. This situation after depolymeriza- 
tion more closely resembles the phosphorylation pattern ob- 
tained in non-NGF-treated PC12 cells and suggests that char- 
tin isoforms are derived by sequential phosphorylation or 
dephosphorylation of other family members. 
While the main means of modification of chartins appears 
to be phosphorylation, the observation that two of the iso- 
forms (A and B in Fig.  3) within the more basic region of 
the 64-72-kD family are not appreciably labeled with [32p]_ 
orthophosphate invites the possibility that additional types of 
modification may occur. Also, although microtubule depoly- 
merization caused a diminution in levels of the more highly 
phosphorylated  chartin  MAP  isoforms,  incorporation  of 
phosphate into the more basic isoforms was  not blocked. 
This suggests that separate mechanisms (i.e.,  different ki- 
nases or phosphatases) may be responsible for regulating the 
phosphorylation of the more basic, soluble isoforms versus 
the more acidic, tubule-associated isoforms. 
In  contrast to their effects on chartins,  depolymerizing 
agents had little effect on the incorporation of phosphate into 
most cellular phosphoproteins. Thus, there appears to be a 
highly specific mechanism involved in regulation of chartin 
phosphorylation by tubules. Of particular interest in this re- 
gard is MAP 1.2.  NGF treatment causes an increase in the 
phosphorylation of this  microtubule-associated species as 
well as the chartin MAPs (2, 7, 20). However, depolymeriz- 
ing agents had only a minor influence on the phosphorylation 
of MAP 1.2. This indicates that different mechanisms under- 
lie  the  regulation  of NGF-promoted increases  in  chartin 
phosphorylations as compared with that of other MAPs. 
Effects of Taxol on Phosphate Turnover in Chartins 
Since  dissolution  of microtubules  caused  loss  of chartin 
phosphorylation,  we  used  the  microtubule  polymerizing 
agent taxol to test whether enhancement of microtubule as- 
sembly and stability would drive chartin phosphorylation. 
We have shown here that taxol does not enhance phosphory- 
lation  of chartins  in  long-term  NGF-treated  PC12  cells. 
Moreover, there was an inhibition of the metabolic labeling 
of several of the acidic isoforms with [nP]orthophosphate. 
This contrasts with the observation that there was much less 
effect of taxol on the total cellular pattern of chartins as re- 
vealed by a 72-h label with methionine. One model consis- 
tent  with  these  data  is  that  acidic  chartin  isoforms  are 
differentially associated  with  tubules  (39)  and  that  when 
these isoforms are associated with taxol-stabilized microtu- 
bules, they undergo a decreased level of phosphate turnover. 
An additional  observation was  that taxol does  not inhibit 
phosphate incorporation into the more basic chartins. This 
further supports the possibility that different mechanisms are 
involved in regulating phosphorylation of the basic versus 
acidic  chartin  isoforms.  Finally,  we found that  when the 
taxol-stabilized cytoskeleton was analyzed, this fraction was 
highly enriched in acidic chartin isoforms. This indicates 
that the more basic chartin isoforms do not associate with 
taxol-stabilized tubules and that they cannot be driven to do 
so in the presence of taxol. 
Our observations regarding the effects of taxol on chartins 
are complemented by recent studies in which sympathetic 
neuron cultures were labeled with  [35S]methionine  in  the 
continuous presence of taxol (5).  Under these conditions, 
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tures, but did not associate with the microtubular cytoskele- 
ton. In our experiments, in which chartins were, in contrast, 
prelabeled  with  [35S]methionine  before addition of taxol, 
there was only a moderate loss of labeled chartins from the 
microtubular cytoskeleton even after 24 h of drug treatment. 
Therefore, if, as implied by the sympathetic neuron experi- 
ments (5),  taxol interferes with association of cytoplasmic 
chartins with microtubules, then the present observations in- 
dicate that introduction of taxol also blocks the capacity of 
bound chartins to dissociate from these structures.  Addi- 
tional 2D IEFxSDS-PAGE analyses of sympathetic neuron 
material (la) have further revealed that the chartins synthe- 
sized in the continuous presence of taxol are not converted 
to  the  highly phosphorylated isoforms.  Our data,  on the 
other hand, suggested that taxol selectively decreases phos- 
phate turnover in tubule-associated chartins. Thus, for cyto- 
plasmic chartins, taxol appears to impede both interaction 
with microtubules and tubule-dependent phosphorylation, 
while for tubule-bound chartin isoforms, this drug blocks 
both dissociation and phosphate turnover. There are several 
possible mechanisms that could account for such findings. 
For instance, by stabilizing the association between tubules 
and bound chartins, taxol could limit exchange of the latter 
with cytoplasmic chartins. Alternatively, taxol could affect 
phosphoprotein phosphatase and/or protein kinase activities, 
and, thereby, chartin phosphorylation and microtubule inter- 
action. 
Neurite Stability 
The  well-established  PC12 neurites  in  long-term  NGF- 
treated cultures used in this study could be maintained under 
conditions in which most cellular microtubules were lost. 
The stability of axons in situ and of neurites in culture under 
conditions favoring disassembly of microtubules has been 
reviewed by Daniels (13). A number of factors may contrib- 
ute to maintaining neuritic processes in the absence of the 
subcellular  support  afforded by microtubule bundles.  At 
least in cell culture, increased stability is correlated with the 
formation of long, mature neurites (23). Joshi et al. (25) ob- 
served that relatively low concentrations of depolymerizing 
drugs caused rapid retraction and disappearance of neurites 
in PC12 cultures that had been exposed to NGF for only a 
short period of time and in  which the processes,  conse- 
quently, were not well developed. In contrast, the neurites 
in the presently described, long-term NGF-treated cultures 
remained extended even in the presence of 10-fold higher 
drug concentrations that eliminated nearly all microtubules. 
One  possible  source  of  this  change  in  dependence  on 
microtubules  is  the  appearance  of intermediate filaments 
such as neurofilaments (12, 50). Previous studies (47) have 
revealed that substantial numbers of intermediate filaments 
can be detected in PC12 cells by electron microscopy only 
after several weeks of exposure to NGF. While it is presently 
unclear whether the filamentous features observed in PC12 
neurites after exposure to nocodazole were drug induced or 
were previously present and undetectable due to the densely 
packed microtubular array, it is possible that these structures 
could provide a subcellular support within neurites even af- 
ter depletion of microtubules. 
Microtubules and Neurite Elongation 
Although we  found that  well-developed  neurites  may be 
maintained for at least 1 d after depolymerization of their 
tubules, they do not continue to elongate under such circum- 
stances. The mechanism through which intact microtubules 
serve to promote growth of neurites is unknown. The micro- 
tubule-based regulation of  chartin MAP phosphorylation de- 
scribed in the present study, however, provides a basis upon 
which a model can be proposed.  Microtubules supply the 
requisite  environment  for  the  maximal  sequential  phos- 
phorylation of chartins, which in turn may lead to growth ei- 
ther by promoting the stable addition of new tubulin subunits 
to the distal tips of tubule bundles or by facilitating interac- 
tions of microtubules with other cytoskeletal or membranous 
elements necessary for generating the formation of stable 
lengths of neurite behind the advancing growth cone. In sup- 
port of this hypothesis, lithium ion (7) and activators of ade- 
nylate cyclase (19) inhibit chartin phosphorylation and also 
interfere with neurite growth without disrupting microtu- 
bules.  Both  microtubules  and  phosphorylated  chartins, 
therefore, appear to be required for elongation. In addition, 
the  NGF-promoted increase  in  levels of the most highly 
phosphorylated chartins is temporally correlated with neu- 
rite outgrowth (2). Moreover, the acidic chartin isoforms are 
also highly enriched, relative to other phosphoproteins, in 
neurites versus cell bodies (1). The presently hypothesized 
roles of microtubules in regulating chartin phosphorylation 
and of phosphorylated chartins in promoting microtubule 
elongation represent testable models for future experimenta- 
tion concerning the molecular events underlying the NGF- 
triggered growth of neurites. 
We are grateful to Federico Negri and Paul Yodice for their excellent techni- 
cal assistance; to Kristy Brown for the electron micrographs; and to Julia 
Cohen, Linda Rata, and E.  G. Aletta for their help in the preparation of 
the manuscript. We also wish to thank Dr. Michael L. Shelanski and Dr. 
Mark M. Black for their helpful comments  on the manuscript and Dr. Frank 
Solomon and Dr.  Nicholas Cowan for kindly providing anti-chartin and 
anti-MAP 1 antisera, respectively. 
This work was supported by National Institutes of Health grant NS 16036 
and by a basic research grant from the March of Dimes Birth Defects Foun- 
dation. L. A. Greene is the recipient of a Career Development Award from 
the Irma T. Hirschl Trust and J. M. Aletta was supported by a postdoctoral 
fellowship from the Muscular Dystrophy Association. 
Received for publication 8 July 1986, and in revised form 13 March 1987. 
References 
1. Aletta, J. M., and L. A. Greene.  1985.  NGF-sensitive phosphoproteins 
from PC12 cells are differentially  localized between cell bodies and neu- 
rites. Soc. Neurosci. Abstr.  11:759. 
la. Black,  M. M. 1987. Taxol interferes with the interaction of microtubule- 
associated proteins with microtubules in cultured neurons. J. Neurosci. 
In press. 
2. Black,  M.  M.,  J.  M.  Aletta,  and L,  A.  Greene.  1986.  Regulation of 
microtubule composition and stability during nerve growth factor (NGF)- 
promoted neurite outgrowth. Jr.  Cell Biol. 103:545-557, 
3.  Black, M. M., and L. A. Greene. 1982. Changes in colchicine susceptibil- 
ity of microtubules associated with neurite outgrowth: studies with nerve 
growth factor-responsive PC12 pheochromocytoma cells. J.  Cell BioL 
95:379-386. 
4. Black, M. M., and J. T. Kurdyla. 1983.  Microtubule-associated proteins 
of neurons. J.  Cell BioL 97:1020-1028. 
5. Black, M. M., and I. Pen& 1986. In vivo taxol treatment alters the solubil- 
ity properties of microtubule-associated  proteins (MAPs) of cultured neu- 
rons. Ann.  iV,  Y. Acad. Sci. 466:426--428. 
6, Bonner, W.  M., and R. A. Laskey.  1974.  A  film detection method for 
tritium-labeled proteins and nucleic acids in polyacrylamide gels. Eur. J. 
Aletta and Greene Microtubules Regulate  Chartin Phosphorylation  289 Biochem. 46:83-88. 
7. Burstein, D. E., P. J. Seeley, and L. A. Greene.  1985. Lithium ion inhibits 
nerve growth factor-induced neurite outgrowth  and phosphorylation of 
nerve growth factor-modulated microtubule-associated proteins. J.  Cell 
Biol.  101:862-870. 
8. Chamberlain, J. P.  1979. Fluorographic detection of radioactivity in poly- 
acrylamide gels  with the water-soluble  fluor,  sodium salicylate.  Anal. 
Biochem.  98:132-135. 
9. Cleveland,  D. W., S.-Y. Hwo, and M. W. Kirschner.  1977. Purification 
of tau, a microtubule-associated protein that induces assembly of microra- 
bules from purified tubulin. J.  Mol. Biol. 116:207-225. 
10.  Cleveland, D. W., S.-Y. Hwo, and M. W. Kirschner.  1977. Physical and 
chemical properties of purified tan factor and the role of tau in microra- 
bule assembly. J.  Mol. Biol. 116:227-247. 
11.  Daniels, M. P. 1972. Colchicine inhibition of nerve fiber formation in vitro. 
J.  Cell Biol.  53:164-176. 
12.  Daniels, M.  1973. Ultrastructural changes in neurons and nerve fibers as- 
sociated with colchicine inhibition of nerve fiber formation in vitro. J. 
Cell Biol. 58:463-470. 
13.  Daniels, M. 1975. The role of microtubules in the growth and stabilization 
of nerve fibers. Ann. N.  Y. Acad. Sci. 253:535-544. 
14.  DeBrabender, M., G. Geuens, R. Nuydens, R. Willebrords, andJ. DeMey. 
1981. Taxol induces the assembly of free mierotubules in living cells and 
blocks  the  organizing  capacity  of the  centrosomes  and  kinetochores. 
Proc. Natl. Acad. Sci. USA. 78:5608-5612. 
15.  Drubin,  D.  G.,  S.  C.  Feinstein,  E.  M.  Shooter,  and M.  W.  Kirschner. 
1985. Nerve growth factor-induced neurite outgrowth in PC12 cells in- 
volves the coordinate induction of microtubule assembly and assembly- 
promoting factors. J.  Cell Biol. 101 : 1799-1807. 
16.  Dulbecco, R., and M. Vogt.  1954. Plaque formation and isolation of pure 
lines with poliomyelitis viruses. J.  Exp. Med. 99:167-182. 
17.  Gard, D. L., and M. W. Kirschner.  1985. A polymer-dependent increase 
in phosphorylation of [5-tubulin accompanies differentiation of a mouse 
neuroblastoma cell line. J.  Cell Biol. 100:764-774. 
18. Greene,  L.  A.,  D.  E.  Burstein,  and  M.  M.  Black. 1982. The  role  of 
transcription-dependent priming in nerve growth factor promoted neurite 
outgrowth.  Dev. Biol. 91:305-316. 
19.  Greene, L. A., S. A. Drexler, J.  L. Connolly, A. Rukenstein, and S. H. 
Green. 1986. Selective inhibition of responses to nerve growth factor and 
of microtubule-assoeiated protein phosphorylation by activators of ade- 
nylate cyclase. J.  Cell Biol. 103:1967-1978. 
20,  Greene, L. A., R. K. H. Liem, and M. L. Shelanski.  1983. Regulation of 
a high molecular weight microtubule-associated protein by PC 12 cells by 
nerve growth factor..L  Cell Biol. 96:76-83. 
21. Greene, L. A., and A. S. Tischler.  1976. Establishment of a nonadrenergic 
clonal line of rat adrenal pheochromocytoma cells which respond to nerve 
growth factor.  Proc. Natl. Acad. Sci. USA. 73:2424-2428. 
22.  Greene,  L. A., and A. S. Tischler.  1982. PCI2 pheochromocytoma cul- 
rares in neurobiological research.  Adv. Cell. Neurobiol.  3:373-414. 
23. Jacobs,  R.,  and  J.  Stevens.  1983. Reversible  nocodazole  sensitivity  in 
young,  NGF activated PCI2 neurites.  Soc. Neurosci.  Abstr. 9:205. 
24. Job, D., M. Pabion, and R. L. Margolis.  1985. Generation of microtubule 
stability subclasses by microtubule-associated proteins:  implications for 
the  microrabule  "dynamic instability" model.  J.  Cell Biol. 101:1680- 
1689. 
25. Joshi, H. C., D. Chu, R. E. Buxbanm, and S. R. Heidemann.  1985. Ten- 
sion and compression in the cytoskeleton of PCI2 neurites. J. Cell Biol. 
101:697-705. 
26.  Kim, H., L. I. Binder, and J. L. Rosenbaum.  1979. The periodic associa- 
tion of MAP2 with brain microtubules in vitro. J. Cell Biol. 80:266-276. 
27.  Laemmli, U. K.  1970. Cleavage of structural proteins during assembly of 
the head of bacteriophage "1"4. Nature  (Lond.). 222:680-685. 
28.  Laskey, R. A., and A. D. Mills.  1975. Quantitative film detection of 3H 
and  ~4C  in polyacrylamide  gels by fluorography.  Eur. J.  Biochem. 56: 
335-341. 
29.  Lee, V., J.  Q. Trojanowski,  and W.  W. Schlaepfer.  1982. Induction of 
neurofilament triplet proteins in PC12 ceils by nerve growth factor. Brain 
Res. 238:169-180. 
30.  Leterrier,  J.-F., R. K. H. Liem, and M. L. Shelanski.  1982. Interactions 
between neurofilaments and microtubule-associated proteins: a possible 
mechanism for intraorganelle bridging.  J.  Cell Biol. 95:982-986. 
31.  Lewis, S. A., P. Sherline, and N. J. Cowan. 1986. A cloned cDNA encod- 
ing MAP1 detects a single copy gene in mouse and a brain-abundant RNA 
whose level decreases during development. J. Cell Biol. 102:2106-2114. 
32. Lohmann,  S.  M.,  P.  DeCamilli,  I.  Einig,  and  U,  Walter.  1984. High 
affinity binding of the regulatory subunit (Rn) of cAMP-dependent pro- 
tein kinase to microtubule-associated and other cellular proteins.  Proc. 
Natl. Acad. Sci. USA. 81:6713-6727. 
33. Luckenbill-Edds, L., C. Van Horn, and L. A. Greene. 1979. Fine structure 
of initial outgrowth of  processes induced in a pheochromocytoma cell line 
(PCI2) by nerve growth factor. J.  Neurocytol.  8:493-511. 
34. Magendantz,  M., and F.  Solomon.  1986. Analyzing the components of 
microtubules: antibodies against chartins,  associated proteins from cul- 
tured cells.  Proc. Natl. Acad. Sci. USA. 82:6581-6585. 
35.  Mobley, W. C., A. Schenker, and E. M. Shooter.  1976. Characterization 
and isolation of proteolytically modified nerve growth factor. Biochemis- 
try.  15:5543-5552. 
36. Murphy,  D. B.,  and G. G. Borisy.  1975. Association of high molecular 
weight proteins with microtubules and their role in microtubule assembly 
in vitro.  Proc. Natl. Acad. Sci. USA. 72:2696-2700. 
37.  Nairn, A. C., H. C. Hemmings, Jr., and P. Greengard.  1985. Protein ki- 
nases in the brain. Ann.  Rev. Biochem.  54:931-976. 
38. O'Farrell,  P. H. 1975. High resolution two-dimensional electrophoresis of 
proteins.  J.  Biol. Chem. 250:4007--4021. 
39.  Pallas,  D.,  and F.  Solomon.  1982. Cytoplasmic  microtubule-associated 
proteins: phosphorylation at novel sites is correlated with their incorpora- 
tion into assembled microtubules.  Cell. 30:407-414. 
40.  Peng, I., L. I. Binder, and M. M. Black. 1985. Cultured neurons contain 
a variety of microtubule-associated proteins.  Brain Res. 361:200-211. 
41.  Peng, J., L. I. Binder, and M. M. Black. 1986. Biochemical and immuno- 
logical analysis of cytoskeletal domains of neurons.  Z  Cell Biol. 102: 
252-262. 
42.  Schiff, P. B., J. Fant, and S. B. Horwitz.  1979. Promotion of microtubule 
assembly in vitro by taxol.  Nature  (Lond.). 277:665-667. 
43.  Schiff, P. B., and S. B. Horwitz.  1981. Taxol assembles tubulin in the ab- 
sence of exogenous guanosine 5'-triphosphate or microtubule-associated 
proteins.  Biochemistry.  20:3247-3252. 
44.  Seldon, S. C., and T. D. Pollard.  1983. Phosphorylation of microtubule- 
associated proteins  regulates their  interactions with actin filaments. J. 
Cell Biol. 258:7064-7071. 
45.  Sloboda, R. D., S. A. Rudolph, J. L. Rosenbaum, and P. Greengard.  1975. 
Cyclic AMP-dependent endogenous phosphorylation  of a microtubule- 
associated protein.  Proc.  Natl. Acad. Sci. USA. 72:177-181. 
46.  Solomon, F., M. Magendantz, and A. Salzrnan. 1979. Identification with 
cellular microtubules of one of the co-assembly microtubule-associated 
proteins.  Cell.  18:431-438. 
47.  Tischler,  A. S., and L. A. Greene.  1978. Morphologic and cytochemical 
properties of a clonal line of rat adrenal pheochromocytoma cells which 
respond to nerve growth factor.  Lab.  Invest. 39:77-89. 
48. Vale, R. D., T. S. Reese, and M. P. Sheetz. 1985. Identification of a novel 
force-generating protein,  kinesin,  involved in microtubule-based motil- 
ity.  Cell. 42:39-50. 
49. Weingarten, M. D., A. H. Lockwood, S.-Y. Hwo, and M. W. Kirschner. 
1975. A protein factor essential for microtubule assembly. Proc. Natl. 
Acad.  Sci. USA. 72:1858-1862. 
50~ Wisniewski, H., M. L. Shelanski, and R. D. Terry.  1968. Effects of mitotic 
spindle inhibitors on neurotubules and neurofilaments in anterior  horn 
cells. J.  Cell Biol. 38:224-229. 
51. Yamada, K. M., B. S. Spooner, and N. K. Wessells.  1970. Axon growth: 
roles of microfilaments and microtubules.  Proc. Natl. Acad.  Sci. USA. 
66:1202-1212. 
52.  Zieve, G., and F. Solomon. 1984. Direct isolation of neuronal microtubule 
skeletons. Mol. Cell. Biol. 4:371-374. 
The Journal of Cell Biology, Volume  105, 1987  290 